Stocks · Health care · Pharmaceutical Preparations

Vera Therapeutics, Inc.

VERA Clue Score36
United States Fiscal year ends December CIK 0001831828 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Marshall Fordyce
7 Jul 2026
President and CEO
Sold on a plan
2,200
$43.59
$95.91K
Marshall Fordyce
7 Jul 2026
President and CEO
Sold on a plan
10,500
$42.86
$450.01K
Marshall Fordyce
7 Jul 2026
President and CEO
Sold on a plan
32,550
$42.07
$1.37M
Marshall Fordyce
7 Jul 2026
President and CEO
Sold on a plan
1,000
$40.78
$40.78K
Marshall Fordyce
23 Jun 2026
President and CEO
Sold on a plan
88
$38.43
$3.38K
Marshall Fordyce
23 Jun 2026
President and CEO
Sold on a plan
18,412
$37.93
$698.39K
Marshall Fordyce
12 May 2026
President and CEO
Sold on a plan
4,281
$37.09
$158.77K
Marshall Fordyce
12 May 2026
President and CEO
Sold on a plan
14,219
$36.64
$520.98K
Marshall Fordyce
14 Apr 2026
President and CEO
Sold on a plan
900
$45.51
$40.96K
Marshall Fordyce
14 Apr 2026
President and CEO
Sold on a plan
7,921
$44.58
$353.11K
Marshall Fordyce
14 Apr 2026
President and CEO
Sold on a plan
14,130
$43.66
$616.99K
Marshall Fordyce
26 Feb 2025
President and CEO
Sold on a plan
1,100
$28.32
$31.15K
Marshall Fordyce
26 Feb 2025
President and CEO
Sold on a plan
7,975
$27.55
$219.73K
Marshall Fordyce
21 Feb 2025
President and CEO
Sold on a plan
10,613
$27.89
$296.03K
Beth C Seidenberg
28 Oct 2024
Director
Sold on a plan
202
$49.54
$10.01K
Beth C Seidenberg
28 Oct 2024
Director
Sold on a plan
14,798
$48.01
$710.49K
Beth C Seidenberg
19 Sep 2024
Director
Sold on a plan
13,823
$42.31
$584.79K
Beth C Seidenberg
18 Sep 2024
Director
Sold on a plan indirect
1,476
$42.00
$61.99K
Beth C Seidenberg
18 Sep 2024
Director
Sold on a plan
1,177
$42.01
$49.45K
Marshall Fordyce
21 Aug 2023
President and CEO
Sold on a plan
5,210
$16.66
$86.78K
Joanne Curley
21 Aug 2023
Chief Development Officer
Sold on a plan
1,490
$16.66
$24.82K
Celia Lin
21 Aug 2023
Chief Medical Officer
Sold on a plan
1,490
$16.65
$24.82K

What was left out

Form 4 filings counted 193
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 22
Sales straight out of an exercise 139
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 16,126,126
Sales filed before the plan box existed 5
History held since 17 May 2021